fbpx

Tag Archives: Coronavirus insights

How Chile became an unlikely winner in the COVID-19 vaccine race

Veronica Diaz-Cerda, Aston University At first glance, it may seem that the race to acquire COVID-19 vaccines has been won by western nations. But alongside the UK, Canada, USA and EU, another country has also secured a high number of doses relative to its population – Chile. To date Chile has ordered close to 90 million vaccine doses – enough …

Read More »

Lockdown study finds undiagnosed mental health crisis among new mothers

Shutterstock Vicky Fallon, University of Liverpool; Sergio A. Silverio, King’s College London, and Siân Macleod Davies, Liverpool John Moores University New mothers experienced worryingly high rates of depression and anxiety during the first lockdown, our new research has revealed. One of the major contributing factors to them feeling this way was the psychological impact of social distancing measures. Our study …

Read More »

Germany may not give the Oxford-AstraZeneca vaccine to over-65s, but that doesn’t mean it won’t work

Studio Romantic/Shutterstock Paul Hunter, University of East Anglia The Oxford-AstraZeneca vaccine has been receiving a lot of attention recently. The EU has been dissatisfied with production hold-ups, while the German health ministry has raised questions over its efficacy in older age groups. As a result, Stiko – the German Standing Committee on Vaccination – has suggested in a draft recommendation …

Read More »

Is your mask effective against COVID-19? Three questions you should ask yourself

Check your mask for fit, filtration and breathability. Roman Samborskyi/Shutterstock Fiona Henriquez, University of the West of Scotland; Mia Cousins Burleigh, University of the West of Scotland, and William MacKay, University of the West of Scotland The emergence of new, potentially more infectious, coronavirus variants has led many people to worry about the effectiveness of their masks in protecting themselves …

Read More »

Germany may not give the Oxford-AstraZeneca vaccine to over-65s, but that doesn’t mean it won’t work

Studio Romantic/Shutterstock Paul Hunter, University of East Anglia The Oxford-AstraZeneca vaccine has been receiving a lot of attention recently. The EU has been dissatisfied with production hold-ups, while the German health ministry has raised questions over its efficacy in older age groups. As a result, Stiko – the German Standing Committee on Vaccination – has suggested in a draft recommendation …

Read More »

Should people who have recently had COVID be vaccinated?

Matt Webster, Anglia Ruskin University A recent report from Public Health England showed that 83% of people who had had COVID were protected from reinfection five months later. Given that 3.7 million people in the UK have had COVID, should those with antibodies be at the back of the vaccine queue? With the current high death rate, rising case numbers, …

Read More »

COVID-19 vaccines: how and when will lower-income countries get access?

Rory Horner, University of Manchester COVID-19 vaccination programmes are gathering pace in high-income countries, but for much of the world, the future looks bleaker. Although a number of middle-income countries have started rolling out vaccines, widespread vaccination could still be years away. The first two COVID-19 vaccines authorised in Europe and the United States – made by Pfizer/BioNTech and Moderna …

Read More »

Coronavirus: why combining the Oxford vaccine with Russia’s Sputnik V vaccine could make it more effective

Jim Barber/Shutterstock Jameel Inal, University of Hertfordshire When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion. The overall efficacy of the vaccine at stopping people developing symptomatic COVID-19, two weeks after the second dose, was 70%. But this wasn’t the whole picture. This figure was based on averaging the results from two groups. …

Read More »